Literature DB >> 31233218

Accuracy of clinical scoring tools for the diagnosis of pediatric obstructive sleep apnea.

Anant P Patel1, Sheneen Meghji2, John S Phillips2.   

Abstract

OBJECTIVES: To assess the diagnostic test accuracy of questionnaire and clinical examination-based scoring tools in the diagnosis of pediatric obstructive sleep apnea (OSA).
METHODS: A comprehensive literature search was performed to identify studies published from 1960 to 2018 that evaluated the accuracy of clinical scoring tools in the diagnosis of pediatric OSA. Studies that did not include attended polysomnography as a reference standard were excluded. The study populations were children under 18 years old without craniofacial abnormalities, congenital syndromes, or other complex medical conditions. Outcomes measures were diagnostic test accuracy (DTA) statistics including sensitivity, specificity, and area under the curve (AUC) from receiver operating characteristic curve analysis.
RESULTS: Fifteen different scoring tools were identified. Authors chose different polysomnographic criteria to diagnose OSA. Four of the tools had undergone multiple DTA studies by different authors (OSA Score, Sleep-Related Breathing Disorder [SRBD] scale, Severity Score, and OSA-18). The Pediatric Sleep Questionnaire SRBD scale, which is widely used, has a sensitivity of 71% to 84% in included studies, but specificity as low as 13% and a low AUC of 0.57-0.69, indicating poor diagnostic accuracy. None of the 15 scoring tools performed well enough to be considered accurate diagnostic tests for pediatric OSA.
CONCLUSIONS: A well-designed questionnaire can provide crucial information on the impact of sleep-disordered breathing on a child's physical and psychological health, which may not be adequately reflected in objective polysomnography outcomes measures. However, DTA results indicate that published clinical scoring tools do not accurately predict a diagnosis of pediatric OSA as defined by polysomnography outcome measures. Laryngoscope, 130:1034-1043, 2020.
© 2019 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Obstructive sleep apnea; pediatric airway; sleep

Year:  2019        PMID: 31233218     DOI: 10.1002/lary.28146

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

Review 1.  Evaluation and Management of Children with Obstructive Sleep Apnea Syndrome.

Authors:  Anna C Bitners; Raanan Arens
Journal:  Lung       Date:  2020-03-12       Impact factor: 2.584

Review 2.  Paediatrics: how to manage obstructive sleep apnoea syndrome.

Authors:  Theresa Nh Leung; James Wch Cheng; Anthony Kc Chan
Journal:  Drugs Context       Date:  2021-03-26

3.  Rationalising requests for preoperative sleep studies and postoperative HDU beds: a quality improvement project in paediatric ENT patients undergoing elective surgery.

Authors:  Simon Morris; Rhodri Jones; Paramesh Mankunda Puttasiddaiah; Michael Eales; Heikki Whittet
Journal:  BMJ Open Qual       Date:  2021-11

4.  Association between the intensity of obstructive sleep apnea and skeletal alterations in the face and hyoid bone.

Authors:  Manoela M Soares; Fabio L Romano; Franciele V da Silva Dias; Jaqueline F de Souza; Leila A de Almeida; Carolina S Miura; Carla E Itikawa; Mirian A Matsumoto; Wilma T Anselmo-Lima; Fabiana C P Valera
Journal:  Braz J Otorhinolaryngol       Date:  2020-07-27

5.  Predicting Behavioral Problems from Sleep-disordered Breathing Trajectories. Not an Easy Game.

Authors:  Leila Kheirandish-Gozal; Sherri L Katz
Journal:  Am J Respir Crit Care Med       Date:  2021-03-15       Impact factor: 30.528

6.  Use of facial stereophotogrammetry as a screening tool for pediatric obstructive sleep apnea by dental specialists.

Authors:  Nathalia Carolina Fernandes Fagundes; Terry Carlyle; Oyku Dalci; M Ali Darendeliler; Ida Kornerup; Paul W Major; Andrée Montpetit; Benjamin T Pliska; Stacey Quo; Giseon Heo; Carlos Flores Mir
Journal:  J Clin Sleep Med       Date:  2022-01-01       Impact factor: 4.062

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.